Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?

par Sueki A, Suzuki E, Takahashi H, Ishigooka J
Publié 2016

A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression

par Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J
Publié 2016

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

par Harada T, Inada K, Yamada K, Sakamoto K, Ishigooka J
Publié 2014

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study

par Inada K, Yamada S, Akiyoshi H, Kojima Y, Iwashita S, Ishigooka J
Publié 2020

Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder

par Tsutsumi T, Sugawara H, Ito R, Asano M, Shimizu S, Ishigooka J, Nishimura K
Publié 2016

Association between anxious distress in a major depressive episode and bipolarity

par Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K
Publié 2019

Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey

par Ishigooka J, Hoshino T, Imai T, Yoshida H, Ono M, Ota M, Moriguchi Y, Fujikawa K, Shintani A, Fernandez JL
Publié 2021

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

par Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Takai K, Higuchi T
Publié 2021